Master New Jersey Supreme Court clarifies the risk-utility standard for design defects and holds a product may be deemed defective even without a feasible safer alternative if, on balance, it should not have been marketed at all. with this comprehensive case brief.
O'Brien v. Muskin Corp. is a foundational New Jersey products liability case that sharpened the doctrinal contours of design-defect claims under strict liability. Moving beyond a narrow focus on consumer expectations or the mere presence of warnings, the court embraced a structured risk-utility balancing approach—an analysis that weighs a product's safety risks against its utility, the feasibility of safer designs, and broader social policy considerations.
The decision is especially significant because it makes clear that a plaintiff need not always identify a feasible safer alternative design to prevail. In appropriate cases, a jury may find a product defective if its risks so significantly outweigh its utility that the product should not have been marketed at all. That move, which resists immunizing entire categories of hazardous products merely because they lack an obvious safer configuration, has made O'Brien a touchstone in design-defect jurisprudence and a staple of products liability casebooks.
O'Brien v. Muskin Corp., 94 N.J. 169, 463 A.2d 298 (N.J. 1983)
Plaintiff O'Brien was seriously injured when he dove into a shallow, above-ground, vinyl-lined swimming pool manufactured by Muskin Corporation. He struck the pool's bottom and sustained severe neck injuries. O'Brien alleged that the pool was defectively designed because, among other things, its shallow depth and vinyl liner made the bottom excessively slippery and dangerous during foreseeable uses, including diving and active play, and that any warnings provided were inadequate. At trial, the jury was instructed, in substance, that plaintiff could not prevail on a design-defect theory without proof of a safer alternative design. The jury returned a verdict for the defendants. On appeal, O'Brien argued that the jury instructions misstated New Jersey law by effectively making a feasible alternative design an absolute prerequisite to recovery and by failing to submit a full risk-utility analysis to the jury.
In a strict products liability design-defect action, must a plaintiff prove a feasible safer alternative design to establish defectiveness, or may a jury find a product defective if, under a risk-utility analysis, its risks so outweigh its utility that it should not have been marketed at all?
Under New Jersey strict products liability law, design defectiveness is determined by a risk-utility analysis. A product is defectively designed if, considering relevant factors, its risks outweigh its utility. A plaintiff may establish defectiveness by showing either (1) a feasible safer alternative design that would have reduced or avoided the harm without unduly impairing utility or imposing excessive cost, or (2) even in the absence of a feasible safer alternative, that the product's risks are so disproportionate to its utility that the product should not have been marketed. Evidence of the state of the art and industry practice is relevant but not dispositive; warnings are relevant but do not cure an otherwise defective design. Relevant risk-utility factors include: - Usefulness and desirability of the product - Availability of safer substitute products - Likelihood and severity of injury - Feasibility of designing the product to be safer - User's ability to avoid danger by exercising care - User's anticipated awareness of the danger, including from warnings and general knowledge - Manufacturer's ability to spread or absorb the loss
The court reversed and remanded for a new trial. It held that New Jersey law does not require proof of a feasible safer alternative design in every design-defect case. The jury should be instructed to apply a risk-utility balancing test and may find a product defective if, on balance, it should not have been marketed at all. State-of-the-art and warning evidence may be considered but are not controlling.
The court grounded its decision in the principles of strict products liability aimed at incentivizing manufacturers to internalize accident costs and design safer products. It endorsed risk-utility balancing as the most coherent method to assess design defects, aligning with prior New Jersey authority and influential academic formulations. While acknowledging that a feasible alternative design is often powerful evidence of defectiveness, the court rejected making it an absolute prerequisite, warning that such a rule could immunize dangerous product categories for which no obvious safer configuration exists, even when their social utility is minimal and their risks severe. The court emphasized that warnings alone cannot transform an unreasonably dangerous design into a reasonable one; at most, they are one factor in the risk-utility calculus, particularly as to user awareness and avoidability. Likewise, proof of compliance with the state of the art or industry customs is admissible but not dispositive, since industry standards can lag behind what reasonable safety requires. The court distinguished products of extraordinary social utility that may fall under unavoidably unsafe product principles from products like above-ground pools, which do not typically present life-saving benefits. Because the trial court's instructions effectively required plaintiff to prove a feasible alternative design and did not properly articulate risk-utility factors, the jury was misled about the governing legal standard, necessitating a new trial.
O'Brien is a landmark decision in New Jersey design-defect law. It cements risk-utility balancing as the operative standard, clarifies that feasible alternatives are not invariably required, and permits the jury, in appropriate cases, to conclude that a product should never have been marketed. For law students, O'Brien illustrates the interplay between warnings, state-of-the-art evidence, and policy-based balancing in strict liability, and it highlights how courts avoid categorical immunity for hazardous products. The case also provides context for subsequent statutory developments, including New Jersey's Products Liability Act, which later refined aspects of design-defect proof while leaving O'Brien's analytical framework an essential point of reference.
No. O'Brien holds that while a feasible alternative design is highly relevant and often persuasive, it is not an absolute prerequisite. A plaintiff can prevail if the jury, applying risk-utility factors, finds the product's risks so outweigh its utility that it should not have been marketed at all.
Warnings are relevant to the user's awareness of risks and ability to avoid harm, but they do not automatically cure an unsafe design. If a design is unreasonably dangerous under risk-utility balancing, the presence of warnings will not insulate the manufacturer from liability.
State-of-the-art evidence—what was technologically and scientifically feasible at the time of manufacture—is admissible and can be probative. However, O'Brien treats it as non-dispositive; conformance with then-current technology and industry customs does not automatically negate defectiveness.
O'Brien prioritizes risk-utility balancing over a pure consumer-expectations approach, especially for complex products or hazards that may exceed lay expectations. Consumer expectations remain relevant but are subsumed as one factor in the broader risk-utility framework.
It allowed juries, in appropriate cases, to conclude that a product category should not have been marketed when its risks vastly exceed its utility. This is sometimes called the product-not-to-be-marketed theory. However, the analysis is case-specific, grounded in risk-utility factors, and does not automatically condemn entire categories.
The Act, enacted after O'Brien, codifies and refines design-defect standards, including emphasizing feasible safer alternatives. O'Brien remains a significant pre-Act case framing risk-utility analysis and continues to inform New Jersey courts' understanding of design-defect principles and the role of warnings and state-of-the-art evidence.
O'Brien v. Muskin Corp. is a pivotal products liability case that fortifies risk-utility balancing as the core method for adjudicating design defects in New Jersey. By declining to make proof of a feasible alternative design an absolute requirement, the court preserved the ability of juries to condemn designs whose risks are intolerable in relation to their social utility.
For students and practitioners, O'Brien underscores the multifactor nature of design-defect analysis and the limited, contextual roles of warnings and state-of-the-art evidence. It remains an essential reference point for understanding how courts navigate the difficult policy choices inherent in strict products liability and design safety.
Need to cite this case?
Generate a perfectly formatted Bluebook citation in seconds.
Use our Bluebook Citation Generator →